Cefotaxime Injection, Powder, For Solution
Product Images NDC 0143-9930

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Cefotaxime (NDC 0143-9930). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Cefotaxime For Injection 1)

FDA Label Image

Ndc 0143-9930-01 Cefotaxime For Injection, Usp 500 mg*/vial For Iv Or Im Use Rx Only *each Vial Contains Sterile Cefotaxime Sodium Equivalent To 500 mg Cefotaxime. The Sodium Content Is Approximately 50.5 mg (2.2 Meq) Of Sodium Per Gram Cefotaxime. Dosage, Administration And Reconstitution: See Package Insert. Shake To Dissolve. Retain In Carton Until Time Of Use. Storage: Cefotaxime For Injection In The Dry State Should Be Stored At 20º To 25ºc (68º To 77ºf) [see Usp Controlled Room Temperature]. Protect From Light. (Cefotaxime For Injection 2)

Cefotaxime for Injection is a medication used for both intravenous or intramuscular purposes. It comes in a 500 mg per vial dose. The medication should be shaken before use and stored in the carton until the time of use. The text suggests further dosage and administration instructions but these are unreadable through the and therefore not available. The text also mentions the manufacturer, M. HIOIAFRMACELTICAFORTUGAL, and provides an address in Bl Hoighs, 07222.*

FDA Label Image

Ndc 0143-9931-01 Cefotaxime For Injection, Usp 1 G*/vial For Iv Or Im Use Rx Only *each Vial Contains Sterile Cefotaxime Sodium Equivalent To 1 G Cefotaxime. The Sodium Content Is Approximately 50.5 mg (2.2 Meq) Of Sodium Per Gram Cefotaxime. Dosage, Administration And Reconstitution: See Package Insert. Shake To Dissolve. Retain In Carton Until Time Of Use. Storage: Cefotaxime For Injection In The Dry State Should Be Stored At 20º To 25ºc (68º To 77ºf) [see Usp Controlled Room Temperature]. Protect From Light. (Cefotaxime For Injection 3)

This is a description of a medication called Belolaxime. It is an injection that contains 500mg of Cefotaxime Sodium. Each package contains 10 vials. Belolaxime is used for intravenous or intramuscular administration. The package insert should be consulted for dosage, administration, and reconstitution instructions. It must be stored at 20°C to 25°C, away from light, in the dry state. This medication is distributed by Hikma Farmaceutica (Portugal) SA and marketed by Hikma, Bereley Heights, NJ.*

FDA Label Image

Ndc 0143-9933-01 Cefotaxime For Injection, Usp 2 G*/vial For Iv Or Im Use Rx Only *each Vial Contains Sterile Cefotaxime Sodium Equivalent To 2 G Cefotaxime. The Sodium Content Is Approximately 50.5 mg (2.2 Meq) Of Sodium Per Gram Cefotaxime. Dosage, Administration And Reconstitution: See Package Insert. Shake To Dissolve. Retain In Carton Until Time Of Use. Storage: Cefotaxime For Injection In The Dry State Should Be Stored At 20º To 25ºc (68º To 77ºf) [see Usp Controlled Room Temperature]. Protect From Light. (Cefotaxime For Injection 4)

Cefotaxime for Injection, USP is a type of medication used for intravenous or intramuscular administration. Each vial contains 1g of the drug. The dosage, administration, and preparation of the drug are provided on the label. The drug should be stored in a cool and dry place until use. The manufacturer is M. Hijos Farmaceutica Portugal, and the product has been approved by USP.*

FDA Label Image

Cefotaxime For Injection 5

Cefotaxime is a medication that comes in the form of 25 vials, each containing 1g of sterile cefotaxime sodium. It is intended for intravenous or intramuscular use and should be opened by cutting the seal along the dotted line. The medication should be shaken to dissolve, with dosage, administration and reconstitution described in the package insert. Cefotaxime should be stored at 20 to 25°C and protected from light, and should be retained in the carton until time of use. This medication is produced by Hikma Farmaceutica and distributed by Hikma.*

FDA Label Image

Cefotaxime For Injection 6

NDC0143.9833.01 is a label of a drug called cefotaxime, which is used to treat bacterial infections. This drug is in the form of an injection and is sold in a carton which should be retained until the time of storage. The manufacturer of this drug is HIXMA FARMACEUTICA (PORTUGAL), and the label contains some Latin characters. However, the text is not entirely readable and contains errors.*

FDA Label Image

Cefotaxime For Injection 7

This text provides information about a product's identification and expiration details. The GTIN (Global Trade Item Number) is 0301234567896, while the SN (Serial Number) is 1234567890123. The product's expiration date is labeled as MMMYYYY, and the LOT number is ABCDE12345.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.